CH Biomedical,inc. – Trademark Portfolio

Entity Type: 03

CH Biomedical,inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include CH-VAD, VINOVI, BRIOVAD, CH BIOMEDICAL, and BRIOHEALTH GLOBAL. The owner is based in Suzhou.

NW-07-301, Nanopolis Suzhou

Suzhou 215123 , CN

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CH Biomedical,inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (9 filings)

Surgical, medical, dental and veterinary apparatus and instruments

35
Advertising & Business (5 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does CH Biomedical,inc. have?

CH Biomedical,inc. has 13 U.S. trademarks filed with the USPTO. Of these, 10 registered, 3 abandoned.

What trademark classes does CH Biomedical,inc. file in?

CH Biomedical,inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are CH Biomedical,inc.'s most well-known trademarks?

CH Biomedical,inc.'s registered trademark portfolio includes well-known marks such as CH-VAD, VINOVI, BRIOVAD, CH BIOMEDICAL, and BRIOHEALTH GLOBAL. These are among 10 currently registered trademarks in the portfolio.

What is CH Biomedical,inc.'s trademark registration success rate?

CH Biomedical,inc. has a 77% trademark registration rate, with 10 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.